NCT04188067View on ClinicalTrials.gov

TMS for the Treatment of Primary Progressive Aphasia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

August 25, 2024

Study Completion Date

August 25, 2024

Conditions
Logopenic Variant Primary Progressive AphasiaNon-fluent Variant Primary Progressive AphasiaSemantic Variant Primary Progressive Aphasia
Interventions
DEVICE

ACTIVE rTMS

All study participants will receive one block of ACTIVE rTMS. Each block will consist of daily sessions of active rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).

DEVICE

SHAM rTMS

All study participants will receive one block of SHAM rTMS. Each block will consist of daily sessions of SHAM rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).

Trial Locations (1)

02129

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Massachusetts General Hospital

OTHER